An Official Website of the United States Government
Company Information:
Name:
VIRONIKA, LLC
Address:
3601 Spruce Street
Suite G63
Philadelphia, PA 19082-
Suite G63
Philadelphia, PA 19082-
Located in HUBZone:
No
Woman-Owned:
No
Minority-Owned:
No
URL:
N/A
Phone:
N/A
Award Totals:
Award List:
Novel Inhibitors of Latent Epstein Barr Virus Infection
Award Year / Program / Phase:
2009 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Troy Messick
Award Amount:
$268,700.00
Abstract:
DESCRIPTION (provided by applicant): The product that will result from this SBIR program, proposed by Vironika and its consortium partner, The Wistar Institute, is a new (the first) small molecule drug candidate for Epstein-Barr virus (EBV) latent infectio
n, and its associated pathologies. EBV is a… More
Development of a Small Molecule Inhibitor for EBV Latent Infection
Award Year / Program / Phase:
2012 / SBIR / Phase I
Agency:
HHS
Principal Investigator:
Mark Mcdonnell – 215-589-6415
Award Amount:
$336,701.00
Abstract:
DESCRIPTION (provided by applicant): The goal of this SBIR research program is to develop a novel small molecule inhibitor of latent Epstein-Barr Virus (EBV) infection. EBV is a ubiquitous gamma- herpesvirus that has been classified by the World Health Organization as a human carcinogen. Vironika,… More